Top Cancer Stocks in Norway
Browse the largest Norway companies in the world ranked by their Market Capitalization. Global Cancer Companies in Norway market cap is $2.31B.
20 Feb 2025, 16:49 UTC
Companies: 7
🇳🇴1 |  | $0.74 | 0.79% | 1.98B | 2905.71% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇳🇴2 |  | $5.61 | -0.16% | 151.93M | -5.33% | Underperform S&P500 YTD Benchamark | 💊 Pharma | - |
🇳🇴3 |  | $0.26 | 4.57% | 86.51M | -85.89% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇳🇴4 |  | $0.23 | 1.92% | 54.49M | 110.78% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇳🇴5 |  | $0.52 | 4.56% | 20.95M | 19.20% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇳🇴6 |  | $0.21 | -4.12% | 7.38M | -97.97% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇳🇴7 |  | $0.11 | -1.36% | 4.26M | -41.74% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
